Sodium Bicarbonate Injection, Solution
Product Images NDC 51662-1400

6 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Bicarbonate (NDC 51662-1400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How Supplied (STORAGE AND HANDLING)

How Supplied (STORAGE AND HANDLING)
A data table listing Sodium Bicarbonate Injection products with product numbers, NDC numbers, strengths, vial sizes, and package counts. It shows the 4.2% (42 mg/mL) strength in 5 mL single dose flip-top vials and the 8.4% (84 mg/mL) strength in 50 mL single dose flip-top vials, packaged in quantities of 25.*
FDA Label Image
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
The image shows a glass vial of Sodium Bicarbonate Injection, USP, 4.2% (42 mg/mL) by HF Acquisition Co LLC, DBA HealthFirst. It is a clear solution in a 5 mL single-dose vial for intravenous use. The vial has a purple cap and a label with dosage information and QR code. The product is prescription only (Rx only).*
FDA Label Image

Vial 1 (Vial 1)

Vial 1 (Vial 1)
Sodium Bicarbonate Injection USP 4.2%, 2.5 mEq (0.5 mEq per mL), in a 5 mL single dose vial with a purple cap. For intravenous use only. The label indicates it is a sterile solution and prescription only (Rx only). Listing NDC 63323-083-05, the vial is marked for intravenous administration.*
FDA Label Image

Vial 2 (Vial 2)

Vial 2 (Vial 2)
Sodium bicarbonate 42 mg/mL injection solution vial with a purple cap. The label indicates it is sterile, nonpyrogenic, and intended for intravenous use. It contains sodium bicarbonate at 42 mg per mL and water for injection, with carbon dioxide added for pH adjustment. The vial is labeled for prescription use only by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Vial 3 (Vial 3)

Vial 3 (Vial 3)
Clear glass vial with a purple cap containing a colorless liquid, labeled with lot number and expiration date, and marked with Fresenius Kabi Lake Zurich, IL 60047. The vial is an injection solution of Sodium Bicarbonate, 42 mg/mL, manufactured by HF Acquisition Co LLC DBA HealthFirst, with NDC 51662-1400.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.